| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |